These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14714691)

  • 1. Varying the course in patenting genetic material: a counter-proposal to Richard Epstein's steady course.
    Dreyfuss RC
    Adv Genet; 2003; 50():195-208; discussion 507-10. PubMed ID: 14714691
    [No Abstract]   [Full Text] [Related]  

  • 2. Steady the course: property rights in genetic material.
    Epstein RA
    Adv Genet; 2003; 50():153-94; discussion 507-10. PubMed ID: 14714690
    [No Abstract]   [Full Text] [Related]  

  • 3. Enclosing the genome: what squabbles over genetic patents could teach us.
    Boyle J
    Adv Genet; 2003; 50():97-122; discussion 507-10. PubMed ID: 14714688
    [No Abstract]   [Full Text] [Related]  

  • 4. HHS panel examines effects of patents, licenses on genetic testing.
    Lavine G
    Am J Health Syst Pharm; 2009 Jan; 66(2):114, 116. PubMed ID: 19139472
    [No Abstract]   [Full Text] [Related]  

  • 5. The gene patenting controversy: a convergence of law, economic interests, and ethics.
    Kevles DJ; Berkowitz A
    Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549
    [No Abstract]   [Full Text] [Related]  

  • 6. Jurisprudence and genetics.
    Kaveny MC
    Theol Stud; 1999 Mar; 60(1):135-47. PubMed ID: 12452148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fate and future of patents on human genes and genetic diagnostic methods.
    Huys I; Matthijs G; Van Overwalle G
    Nat Rev Genet; 2012 May; 13(6):441-8. PubMed ID: 22596320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it right or is it useful? Patenting of the human gene, Lockean property rights, and the erosion of the imago Dei.
    Cunningham PC
    Ethics Med; 2003; 19(2):85-98. PubMed ID: 15025114
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical aspects of patenting human genotypes according to EC Biotechnology Directive.
    Spranger TM
    IIC Int Rev Ind Prop Copyr Law; 2000 Jun; 31(4):373-80. PubMed ID: 12956125
    [No Abstract]   [Full Text] [Related]  

  • 10. It is not unethical, though it is often unwise, to override patents.
    Leventer H
    Am J Bioeth; 2002; 2(3):50-1. PubMed ID: 12230860
    [No Abstract]   [Full Text] [Related]  

  • 11. Playing God? Owning God?--Patenting and the human genome.
    Kirby M
    Univ N S W Law J; 2003; 26(3):770-81. PubMed ID: 16617531
    [No Abstract]   [Full Text] [Related]  

  • 12. Patenting pieces of people.
    Nat Biotechnol; 2003 Apr; 21(4):341. PubMed ID: 12665804
    [No Abstract]   [Full Text] [Related]  

  • 13. Patenting medical procedures: a search for a compromise between ethics and economics.
    Gocyk-Farber B
    Cardozo Law Rev; 1997; 18():1527-67. PubMed ID: 12173633
    [No Abstract]   [Full Text] [Related]  

  • 14. Patenting and licensing in genetic testing: ethical, legal, and social issues.
    Soini S; Aymé S; Matthijs G;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-50. PubMed ID: 18557182
    [No Abstract]   [Full Text] [Related]  

  • 15. A Lockean argument against gene patenting.
    Murray D
    Bus Prof Ethics J; 2001; 20(3-4):129-43. PubMed ID: 15195649
    [No Abstract]   [Full Text] [Related]  

  • 16. Patents: the public interest versus the private privilege.
    Parsi KP; Egan EA
    Am J Bioeth; 2002; 2(3):45-6. PubMed ID: 12230857
    [No Abstract]   [Full Text] [Related]  

  • 17. Reaching through the genome.
    Eisenberg RS
    Adv Genet; 2003; 50():209-30; discussion 507-10. PubMed ID: 14714692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dangers of diagnostic monopolies.
    Cook-Deegan R; Chandrasekharan S; Angrist M
    Nature; 2009 Mar; 458(7237):405-6. PubMed ID: 19325608
    [No Abstract]   [Full Text] [Related]  

  • 19. Whistling in the wind: patents on genetic research are a reality. It's time to reframe the debate.
    Caulfield TA; Gold ER
    Forum Appl Res Public Policy; 2000; 15(1):75-9. PubMed ID: 17333589
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
    Resnik DB; DeVille KA
    Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.